A recent study found combinations of five genetic variations help predict a man’s probability of being diagnosed with prostate cancer. But what should one do with such information? And how might genetic information like this change the way we approach medical problems?

Guests

  • Fernando Bianco Dr. Fernando Bianco, MD, is the Chief of Urology Oncology for the Department of Urology at The George Washington University Hospital.
  • Karim Kader Dr. Karim Kader MD, PHD, is an Assistant Professor of Urology at Wake Forest University.
  • Amy Harmon Amy Harmon is a reporter for the New York Times. Her ongoing series, "The DNA Age" examines the impact of genetic science on American life.

Topics + Tags

Most Recent Shows